Read More

On October 16, 2023, Aligos Therapeutics Entered Into Settlement Agreement With Janssen Biotech Providing For Resolution Of Previously Disclosed Action Brought By Janssen Alleging Breach Of Contract Aligos CEO, Others

8-k - On October 16, 2023, Aligos Therapeutics, Inc. (the “Company”) entered into a settlement agreement (the “Settlement Agreement”) withJanssen Biotech, Inc. (successor in interest to Janssen

ALGS